Menu
ncarol.com
  • Home
  • Business
  • Insurance
  • Books
  • Real Estate
  • Construction
  • Financial
  • Education
  • Health
ncarol.com

Target RWE Acquires NoviSci Inc., Adding Significant Analytical Capabilities to Leading Real-World Evidence Platform
ncarol.com/10096012

Trending...
  • Cymatic Takes Top Honors for the Second Consecutive Year in the 17th Annual 2021 Cyber Security Global Excellence Awards
  • Dole Launches "The Dole Way" Sustainability Campaign
  • Liquid Core® Gum Company announces TDA Boulder Creative Director Jonathan Schoenberg has joined its Advisory Board
DURHAM, N.C.--(BUSINESS WIRE)--Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries based in Durham, North Carolina, today announced the acquisition of NoviSci, Inc., a software analytics and services company whose innovative technologies enable the visualization and analysis of health data using modern epidemiological methods and sound scientific principles. The acquisition significantly broadens Target RWE's data analytics capabilities and will enable the company to meet increasing demand for high quality evidence from real-world data.

Related to this acquisition, Amgen Inc., a strategic investor in and collaborator with NoviSci, has also made a strategic investment in the combined company to fuel growth, joining existing Target RWE investors Norwest Venture Partners and 22C Capital. This expanded partnership further validates the importance of real-world data on a global scale and the differentiated capabilities and solutions that Target RWE and NoviSci offer together. Financial terms of the transactions were not disclosed.

Neal Bibeau, Chief Executive Officer of Target RWE, said, "Target RWE's proven real-world data and evidence solutions continue to grow in breadth, depth and value for our research and industry partners. With the addition of NoviSci's novel analytics platform and experienced team, Target provides a highly adaptive environment to accelerate insights and reproducible research output from real-world data to various stakeholders in the healthcare ecosystem, including our pharmaceutical industry partners, healthcare investigator partners, government agencies and payor organizations."

More on ncarol.com
  • Asensus Surgical Announces Finalization of Name and Ticker Symbol Change
  • Calvetta Phair, CEO of PEP Travel Group and Waldron McCritty, CEO of BE LUX, Alumni of ASCEND 2020, form teaming alliance to promote Luxury Hospitality
  • Adare Biome™ Enters North American Distribution Through Stratum Nutrition® for LBiome™ Postbiotic
  • Dole Launches "The Dole Way" Sustainability Campaign
  • ConvergeOne and Evolve IP Enter Strategic Hospitality Partnership

"Now more than ever, real-world evidence solutions are transforming healthcare. Our expanding longitudinal, observational data augmented with new sources of data allow for deep characterization of patient journeys across a broad range of diseases and treatments," added Michael W. Fried, MD, FAASLD, Chief Medical Officer and Co-founder of Target RWE. "NoviSci's expertise and novel analytical software complements our leading real-world evidence platform, and we look forward to integrating these products to enable accelerated growth in our industry."

Durham-based NoviSci, Inc. applies epidemiologic methods and causal inference techniques from the fields of epidemiology and statistics to complex real-world data to support its partners in research and industry. NoviSci has built a novel repository of rigorously developed interactive real-world studies that can be adapted to new datasets and populations. All study results are rendered in NoviSci's secure web-based environment, featuring interactive content and compelling data visualizations that can be updated with accumulating data. NoviSci's tools also support all critical aspects of scientific knowledge production, peer review, and sharing.

M. Alan Brookhart Ph.D., Co-Founder and Chief Scientist of NoviSci and Professor of Population Health Sciences at Duke University, said, "We are delighted to have the opportunity to apply our analytic technology to Target RWE's unique data assets and to provide timely, relevant, and useful answers to important questions posed by stakeholders across the healthcare ecosystem."

Aaron McKethan, Co-Founder and CEO of NoviSci added, "Our goal is to make it easier and faster to answer important questions in health care that result in better outcomes for people and populations. We have sought to use technology to bring the craft of scientific expertise to greater scale, particularly as research methods and data sources have become more complex."

More on ncarol.com
  • Home2 Suites by Hilton Tucson Airport Celebrates Topping Off - Tucson's Newest Extended-Stay Hotel
  • Truthset and the ANA AIMM Release First of its Kind Multicultural Online Data Benchmarks
  • North Carolina: New Satellite Internet Pilot Program to Connect Students in Two N.C. Counties
  • Julia Hair Tax Refund Season Flash Sale Week With Buy Now Pay Later
  • The Best Virgin Hair Vendors 2021

About Target RWE

Headquartered in Durham, NC, Target RWE is an innovative health evidence solutions company generating real-world evidence (RWE) and delivering regulatory-grade data to partners to advance clinical, medical, and commercial outcomes as well as to improve patient health guidelines and quality of care.

Target RWE designs custom data sets, analyses, and evidence to address the complexities of healthcare evidence questions and quality initiatives. Target RWE has developed a turnkey health evidence solution which rapidly aggregates real-world data (RWD) from a large network of participating sites (academic and community) across the United States, Europe, and other non-U.S. locations. Target RWE's data sets are aggregated from various data sources including registries, electronic medical records, patient outcomes measures, biospecimen analyses, and claims databases. Target RWE is backed by Norwest Venture Partners, 22C Capital and other strategic investors.

Visit www.targetrwe.com for more details.

About NoviSci Inc.

Headquartered in Durham, NC, NoviSci's mission is to use principled data science to improve population health outcomes for vulnerable patients with complex conditions. The company's novel analytic applications facilitate the efficient deployment of complex research methods from epidemiology and statistics as well as intuitive, interactive visualization of complex results from real-world studies. NoviSci's founders and leaders continue to hold faculty appointments, including at the Duke University School of Medicine and the University of North Carolina at Chapel Hill. NoviSci previously received seed investment from Amgen Ventures and Hatteras Venture Partners and is based in the American Underground campus in downtown Durham, NC.

Visit www.novisci.com for more details.stats
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Mental Health Advocate Offers Hope to Millions with Book Detailing Trials and Triumphs on His Journey to Leading a Meaningful Life
  • HSUS Applauds Congressional Action on Domestic PPE Production
  • Dedication To Community Launches Historic Partnership With Boston College Athletics
  • Vontier Announces Proposed Private Offering of Senior Unsecured Notes
  • Construction Technology Startup Mosaic Hires Real Estate Veteran as First CFO
  • First look: Clark Nexsen completes engineering building at NC State University
  • North Carolina: Gov. Cooper Announces Frontline Essential Workers Eligible for Vaccination Beginning March 3
  • Embedded Analytics Provider Syncfusion Recognized in Gartner Hype Cycle for Analytics and Business Intelligence, 2020
  • 2021 Marketing Excellence Awards—Call for Entries: Honoring the Best in B2B Services and Solutions Marketing
  • edjuster Launches Fully Interactive Digital Contents Claims Portal
  • Senseeker Engineering Acquires SE-IR Corporation
  • EchoPark Automotive Awarded a 2021 DealerRater Consumer Satisfaction Award
  • Kuester Management Group Details Importance of Clear Architectural Policies
  • North Carolina: Cooper Issues Executive Order to Connect Unemployed with Jobs
  • FinTech Collateral Velocity Closes Investment Round
  • eMoney Advisor Veterans Start Firm to Help Fintech CEOs Jump Start Growth
  • North Carolina: Governor Statement on Senate Bill 37
  • North Carolina: Governor Cooper Proclaims March 2021 as Students@Work℠ Month
  • Charlotte-Mecklenburg Housing Partnership Announces Name Change to DreamKey Partners
  • Florida small town festival ranks Top 50 BEST in nation
_catLbl0 _catLbl1

Popular on ncarol.com

  • ProStrategix Proud To Announce Being Chosen as a Top Web Design Agency by DesignRush
  • Samaritan's Purse Airlifts 30+ Tons Of Food Supplies To Conflict-Stricken Ethiopia; Thousands Of Children At Risk Of Severe Malnutrition
  • BrainKraft and career.pm Announce Product Launch Partnership
  • Anxiety Diary of an Ordinary Girl Book Release Announcement
  • North Carolina: Governor Names Department of Commerce Secretary
  • Recording Artist "Cherne" Crystal Brown auditions for Sony Music, Atlantic Records and Capitol Records and it doesn't stop there
  • BitTube Joins BPSAA as New Alliance Member
  • MiaSolé, Solliance Break World Record Efficiency Of 26.5% On A Tandem Solar Cell Based On A Flexible CIGS Solar Cell On Feb 10, 2021
  • Where's the real justice, and why did this family have to suffer. Please support the fund
  • Tracy Sumner Releases New Regency Romance - The Duke is Wicked

Similar on ncarol.com

  • Asensus Surgical Announces Finalization of Name and Ticker Symbol Change
  • Dole Launches “The Dole Way” Sustainability Campaign
  • Julia Hair Tax Refund Season Flash Sale Week With Buy Now Pay Later
  • Cymatic Takes Top Honors for the Second Consecutive Year in the 17th Annual 2021 Cyber Security Global Excellence Awards
  • Zilker Partners Acquires Growth Digital, Forming One-of-a-Kind Firm
  • SMN Web Services announces its graphics partnership with Blazin Graphxx Studios
  • Vontier Announces Pricing of Private Offering of $1.6 Billion of Senior Notes
  • Tech Startup to Offer Up To 100% Funding Aid to Individuals for Covering Their Education or Travel Expenses
  • HSUS Applauds Congressional Action on Domestic PPE Production
  • Vontier Announces Proposed Private Offering of Senior Unsecured Notes
Copyright © 2021 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute